Albuterol sulfate inhalation solution efficacy
Pro Research Analysisby 
Searched over 200M research papers
Albuterol Sulfate Inhalation Solution Efficacy in Asthma and Bronchiolitis
Efficacy in Asthma: Lung Function and Symptom Relief
Albuterol sulfate inhalation solution is effective in improving lung function and relieving symptoms in patients with asthma. Studies show that both metered-dose inhalers (MDI) and dry powder inhalers (DPI) containing albuterol sulfate significantly improve forced expiratory volume in one second (FEV1) compared to placebo, with no significant difference between the two delivery methods. Both forms are well tolerated and provide similar clinical benefits for patients with mild to moderate asthma 36. In elderly patients with acute asthma, albuterol sulfate aerosol inhalation alone improves symptoms and lung function, but combining it with oral theophylline tablets results in even greater improvement and a lower incidence of adverse reactions 59.
Efficacy in Pediatric Asthma: Combination Therapies
For children experiencing acute asthma attacks, albuterol sulfate inhalation solution alone improves peak expiratory flow (PEF) and clinical symptoms. However, combining albuterol sulfate with magnesium sulfate via aerosol inhalation leads to even better clinical outcomes and faster symptom relief, although the addition of magnesium sulfate does not provide significant extra benefit over albuterol alone in improving FEV1 at 10 and 20 minutes after inhalation 410.
Efficacy in Bronchiolitis and Capillary Bronchitis
In pediatric patients with bronchiolitis or capillary bronchitis, albuterol sulfate inhalation solution, especially when combined with budesonide, results in rapid improvement of symptoms such as cough, wheezing, and chest oppression, and shortens the duration of hospitalization. The combination therapy also reduces the recurrence rate of wheezing compared to conventional treatments 18.
Efficacy in COPD: Combination with Ipratropium Bromide
For patients with chronic obstructive pulmonary disease (COPD), albuterol sulfate inhalation solution provides significant bronchodilation. When combined with ipratropium bromide, the therapy is more effective than either drug alone or albuterol base alone, leading to greater improvements in spirometric measures such as FEV1 and forced vital capacity (FVC), without increasing adverse effects 27.
Safety and Tolerability
Across studies, albuterol sulfate inhalation solution is generally well tolerated, with adverse events similar to those seen with placebo or other active treatments. No new safety concerns have been identified, and the combination therapies do not increase the risk of side effects 2367+1 MORE.
Conclusion
Albuterol sulfate inhalation solution is effective for improving lung function and relieving symptoms in asthma, bronchiolitis, and COPD. Its efficacy is enhanced when combined with other agents such as budesonide, theophylline, or ipratropium bromide, depending on the condition being treated. The solution is safe and well tolerated, making it a reliable option for both pediatric and adult patients.
Sources and full results
Most relevant research papers on this topic
The Clinical Efficacy Observation about Budesonide Suspension with Albuterol Sulfate Solution by Inhalation to Treat Bronchiolitis
Budesonide suspension combined with albuterol sulfate solution by inhalation significantly improves symptoms and shortens hospitalization duration in children with bronchiolitis.
Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials
AS MDI 180 g is an equivalent dose to Proventil for bronchodilation in patients with asthma, supporting its selection for Phase III clinical trials.
Effect of Inhaled Magnesium Sulfate on Bronchial Hyperresponsiveness
Nebulized albuterol and magnesium sulfate + albuterol are more effective in improving FEV1 in children with bronchial hyperresponsiveness than nebulized magnesium sulfate at 10 and 20 minutes after inhalation.
Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
HFA-134a albuterol sulfate provides bronchodilation comparable to CFC albuterol and has a similar safety profile in patients with asthma.
DOI